NANOBIOTIX S.A. SP.ADR Total Liabilities

Latest as of December 2025: €152.24 Million EUR ≈ $177.99 Million USD

NANOBIOTIX S.A. SP.ADR total liabilities. Based on the latest financial reports, NANOBIOTIX S.A. SP.ADR (5NRA) has total liabilities worth €152.24 Million EUR (≈ $177.99 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See 5NRA days of operational coverage to measure how many days the company can operate on defensive assets alone.

Total Liabilities of NANOBIOTIX S.A. SP.ADR (2021–2025)

Total liabilities of NANOBIOTIX S.A. SP.ADR from 2021 to 2025. This chart illustrates how NANOBIOTIX S.A. SP.ADR's total liabilities have evolved over time, based on quarterly financial data. Explore how much of NANOBIOTIX S.A. SP.ADR's assets are long-term investments to see how much of total assets are deployed in long-term investments.

NANOBIOTIX S.A. SP.ADR Competitors by Total Liabilities

The table below lists competitors of NANOBIOTIX S.A. SP.ADR ranked by their total liabilities.

Company	Country	Total Liabilities
Siam Global House Public Company Limited BK:GLOBAL	Thailand	฿14.40 Billion
Inwido AB ST:INWI	Sweden	Skr6.32 Billion
TD Power Systems Limited NSE:TDPOWERSYS	India	Rs8.05 Billion
Jasa Marga Tbk JK:JSMR	Indonesia	Rp97.08 Trillion
Cansino Biologics Inc SHG:688185	China	CN¥-4.93 Billion
China Modern Dairy Holdings Ltd F:07M	Germany	€26.76 Billion
Hannstar Display Corp TW:6116	Taiwan	NT$9.58 Billion
Hunan Boyun New Materials Co Ltd SHE:002297	China	CN¥970.26 Million

Liability Composition Analysis (2021–2025)

This chart breaks down NANOBIOTIX S.A. SP.ADR's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NANOBIOTIX S.A. SP.ADR assets under control.

Liquidity & Leverage Metrics

NANOBIOTIX S.A. SP.ADR Total Liabilities Ratios Explained

NANOBIOTIX S.A. SP.ADR total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.09	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.80	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	2.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NANOBIOTIX S.A. SP.ADR's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NANOBIOTIX S.A. SP.ADR (2021–2025)

The table below shows the annual total liabilities of NANOBIOTIX S.A. SP.ADR from 2021 to 2025.

Year	Total Liabilities	Change
2025-12-31	€152.24 Million ≈ $177.99 Million	+14.36%
2024-12-31	€133.12 Million ≈ $155.63 Million	+39.04%
2023-12-31	€95.74 Million ≈ $111.93 Million	+10.28%
2022-12-31	€86.81 Million ≈ $101.49 Million	+15.79%
2021-12-31	€74.98 Million ≈ $87.66 Million	--

About NANOBIOTIX S.A. SP.ADR

F:5NRA Germany Biotechnology

Market Cap

$1.55 Billion

€1.33 Billion EUR

Market Cap Rank

#7825 Global

#1071 in Germany

Share Price

€27.40

Change (1 day)

+2.24%

52-Week Range

€2.82 - €34.80

All Time High

€34.80